CardioAcademic,
#JACCBTS Editors’ Insights: Results from OPTIMUS-5 study reveal vorapaxar leads to greater clinical benefit when added to the…
#JACCBTS Editors’ Insights: Results from OPTIMUS-5 study reveal vorapaxar leads to greater clinical benefit when added to the…
#JACCBTS Editors’ Insights: Results from OPTIMUS-5 study reveal vorapaxar leads to greater clinical benefit when added to the…
#ESCCongress study finds that vorapaxar is associated with reduced platelet-mediated thrombogenicity without affecting clot…